Moving from probiotics to precision probiotics
Nat Microbiol
.
2020 Jul;5(7):878-880.
doi: 10.1038/s41564-020-0721-1.
Authors
Patrick Veiga
#
1
,
Jotham Suez
#
2
,
Muriel Derrien
3
,
Eran Elinav
4
5
Affiliations
1
Danone Nutricia Research, Palaiseau, France. Patrick.VEIGA@danone.com.
2
Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
3
Danone Nutricia Research, Palaiseau, France.
4
Immunology Department, Weizmann Institute of Science, Rehovot, Israel. eran.elinav@weizmann.ac.il.
5
Cancer-Microbiome Division Deutsches Krebsforschungszentrum (DKFZ), Neuenheimer Feld, Heidelberg, Germany. eran.elinav@weizmann.ac.il.
#
Contributed equally.
PMID:
32393856
DOI:
10.1038/s41564-020-0721-1
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Precision Medicine* / methods
Probiotics* / administration & dosage
Probiotics* / therapeutic use
Grants and funding
HHMI/Howard Hughes Medical Institute/United States